KYTX

NASDAQStock

Kyverna Therapeutics, Inc.

$8.78-0.01 (-0.11%)

52-Week Range

$1.83

$10.82

Key Stats

Market Cap

384.5M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.35

Volume

275.4K

Avg Volume

608.5K

Performance

+11.97%

+0.11%

+124.81%

YTD

+0.23%

+247.43%

-70.70%

Price Chart

ETF Exposure

KYTX is held by 12 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SURI	Simplify Propel Opportunities ETF	2.32%	192,339	$1.8M	$76.5M	2.82%
IWC	iShares Micro-Cap ETF	0.05%	63,802	$589K	$1.27B	0.60%
IBBQ	Invesco Nasdaq Biotechnology ETF	0.03%	2,433	$22K	$74.5M	0.19%
IBB	iShares Biotechnology ETF	0.03%	254,656	$2.4M	$8.50B	0.44%
BIB	ProShares - Ultra Nasdaq Biotechnology	0.02%	1,967	$18K	$86.8M	1.19%
AVSC	Avantis U.S. Small Cap Equity ETF	0.02%	49,874	$460K	$2.37B	0.25%
SCHA	Schwab U.S. Small-Cap ETF	0.01%	110,890	$1.0M	$20.05B	0.04%
DFAS	Dimensional - US Small Cap ETF	0.00%	15,873	$147K	$12.82B	0.26%
VXF	Vanguard Extended Market ETF	0.00%	235,746	$1.9M	$84.10B	0.05%
VTI	Vanguard Total Stock Market ETF	0.00%	1,347,397	$10.8M	$2.10T	0.03%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	4,410	$41K	$41.36B	0.17%
SCHB	Schwab U.S. Broad Market ETF	0.00%	15,000	$138K	$38.14B	0.03%

About KYTX ETF Exposure

Kyverna Therapeutics, Inc. (KYTX) is held by 12 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 384.5M, KYTX is a widely held institutional stock. The stock currently trades at $8.78. Investors can gain exposure to KYTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold KYTX, sorted by portfolio weight.